Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (271 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 08 Apr 2025 – 20 Aug 2026, limited by Tata BSE Quality Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Tata BSE Quality Index Fund | Nifty 500 |
|---|---|---|
| 08 Apr 2025 | ₹100.00 | ₹100.00 |
| 20 May 2025 | ₹113.79 | ₹110.28 |
| 30 Jun 2025 | ₹119.54 | ₹115.31 |
| 11 Aug 2025 | ₹111.64 | ₹110.51 |
| 21 Sep 2025 | ₹118.11 | ₹114.68 |
| 02 Nov 2025 | ₹116.90 | ₹115.77 |
| 14 Dec 2025 | ₹118.26 | ₹115.85 |
| 24 Jan 2026 | ₹116.27 | ₹110.87 |
| 07 Mar 2026 | ₹113.98 | ₹109.77 |
| 17 Apr 2026 | ₹119.80 | ₹111.66 |
| 29 May 2026 | ₹120.81 | ₹110.63 |
| 09 Jul 2026 | ₹119.24 | ₹112.70 |
| 20 Aug 2026 | ₹121.00 | ₹114.80 |
| Metric | Tata · Direct · IDCW NAV ₹11.62 Very High risk ★★★☆☆ 1Y | Category median Index Funds · 271 funds |
|---|---|---|
| +4.93% | +5.06% | |
| — | +7.78% | |
| — | +8.94% | |
| — | +10.39% | |
| +14.97% | +7.54% | |
| +5.83% | — | |
| — | +8.12% | |
| — | +12.83% | |
| — | +11.97% | |
| Risk | ||
| 14.03% | 13.54% | |
| -0.11 | 0.16 | |
| -0.16 | 0.22 | |
| -12.15% | -15.77% | |
| Nifty 500 | — | |
| — | +0.53% | |
| — | 1.00 | |
| — | 102.2% | |
| — | 98.0% | |
| 0.41% | 0.34% | |
| ₹57.00Cr | ₹191.88Cr | |
| 0.25% | — | |
| None | — | |
| ₹100 | — | |
| ₹5.00K | — | |
| 87% | 38% | |
| Rakesh Prajapati | — | |
| 08 Apr 2025 | — | |
| 30 | — | |
| 57.5% | — | |
| 0.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.